Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9620 posts found.

Study explores genomic testing approach for unexplained infertility

May 14, 2026 Research and Development infertility

Researchers across the Asia Pacific region have reported findings from a study investigating whether long-read whole genome sequencing could improve …
News

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026 Research and Development Sophia Genetics, Synnovis

Synnovis and SOPHiA GENETICS have announced a collaboration to expand blood-based cancer testing for patients with lung and breast cancer …
News

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026 Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Maninder Kapoor Puri as …
Appointment

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026 Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Abhijit Zutshi as Chief …
Appointment

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026 Research and Development fatty liver disease, phospholipid therapy

A randomised clinical trial has reported that treatment with essential phospholipids (Essentiale) may reduce liver fat and improve symptoms in …
News

New web series explores path from ophthalmic research to patient access

April 28, 2026 Research and Development Opthalmology

A new YouTube web series has been launched to examine how ophthalmic innovations progress from early research through to approved …
News

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026 Research and Development The European Medicines Agency (EMA), plozasiran

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Redemplo (plozasiran) to treat adults with familial chylomicronaemia …
News

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026 Research and Development SynaptixBio, neurodegenerative disease

SynaptixBio has highlighted the potential of speech analysis as a non-invasive way to track disease progression in neurodegenerative conditions, as …
News

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026 Research and Development RWS, kayentis

Kayentis and RWS have announced a partnership aimed at improving confidence in clinical trial data for neuroscience and other complex …
News

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026 Research and Development

The Medicines and Healthcare products Regulatory Agency (MHRA) has secured new funding to expand its AI Airlock programme, aimed at …
News

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026 Research and Development Gesynta Pharma, endometriosis

Gesynta Pharma has dosed the first patient in its phase 2 clinical proof-of-concept trial of vipoglanstat. The trial, NOVA, is …
News

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026 Research and Development

Kainova Therapeutics has announced that the first patient in the European expansion of its DOMISOL phase I/II clinical trial evaluating …
News
drug-trials

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026 Research and Development

Eisai is to begin enrolling participants in its phase 2 study, Study 202, in patients with narcolepsy. The company registered …
News

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026 Research and Development AI, NVIDIA, Roche

Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance graphics processing units (GPUs) across …
News

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026 Research and Development EndoCyclic Therapeutics, FDA, endometriosis

EndoCyclic Therapeutics’ Investigational New Drug (IND) application for its lead programme, ENDO-205, has been approved by the US FDA. With …
News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026